Equine infectious anemia: prospects for control.

The research article highlights the issue of equine infectious anemia (EIA), an infectious disease afflicting horses. Currently, control measures such as testing and quarantine are in place, but with only about 10% of the horse population being tested annually, there’s a need for more sensitive diagnostic tests.

Understanding Equine Infectious Anemia

• Equine infectious anemia (EIA) is a disease that affects horses and is primarily controlled by implementing testing and quarantine regulations across most countries.
• In the United States, approximately 700,000 out of more than seven million horses are tested annually for EIA. However, these statistics reveal that more than 90% of the horse population is not accounted for, creating a large, mostly untested reservoir for the disease.
• EIA can spread rapidly under certain conditions, with possibly devastating effects on localized horse populations.

The Need for Enhanced Testing Methods

• The research indicates a need to develop more sensitive and practical diagnostic tests for EIA to reduce the number of untested horses, thus increasing the accuracy of test results.
• The existence of an untested EIAV (Equine Infectious Anemia Virus) carrier and the potential for contact with uninfected horses ensures the continued transmission of the disease.

Challenges in Controlling EIA

• Although the adherence to sanitary regulations can minimize the likelihood of disease epidemics, the threat of transmission remains due to the high number of untested horses.
• The other factor that cannot be controlled is “chance encounters” between an untested EIAV-infected horse and a test-negative horse where blood feeding insects are abundant. The transmission is efficient if the quantity of EIAV in the blood of the donor horse is high, adding to the complexity of controlling the disease.